{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:10:49Z","timestamp":1779718249246,"version":"3.53.1"},"reference-count":41,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Futurum - Academy for Health and Care in Jonkoping, Sweden","award":["FUTURUM-1003879."],"award-info":[{"award-number":["FUTURUM-1003879."]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Multimorbidity and Comorbidity"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bullous pemphigoid (BP) has been linked to neurological and psychiatric disorders, but no nationwide population-based study has comprehensively examined the association of various comorbidities in BP patients in Sweden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the associations between BP and various comorbidities, comparing these conditions before and after BP diagnosis with a matched control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A nationwide cohort study was conducted in Sweden from 2005 to 2016, including 5,738 BP cases and 17,167 age, sex and county of residence matched controls. Multivariable Cox proportional hazard regression models were used to calculate hazard ratios (HR). Univariable logistic regression assessed pre-diagnosis comorbidities, generating prevalence odds ratios (POR) with 95% confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BP was associated with a significantly higher overall HR for comorbidity (HR: 2.20, 95% CI: 2.08\u20132.33). Before BP diagnosis, the overall comorbidity was significantly increased POR 2.72 (95% CI: 2.56\u20132.90). Pre-diagnosis association included dementia, Parkinson\u2019s disease, epilepsy, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, unipolar\/bipolar disorders, suicide, diabetes, stroke, systemic lupus erythematosus, systemic sclerosis, psoriasis, lichen planus, alopecia areata, and vitiligo. After diagnosis, the overall hazard ratio (HR) for comorbidities was highest within the first year (HR 2.88, 95% CI: 2.68\u20133.10) and remained elevated beyond one year (HR 1.57, 95% CI: 1.44\u20131.71). Post-diagnosis associations remained elevated for dementia, Parkinson\u2019s disease, epilepsy, schizophrenia, unipolar\/bipolar, diabetes, psoriasis, lichen planus and autoimmune diseases such as systemic sclerosis and Sj\u00f6gren\u2019s syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>BP is strongly associated with neurodegenerative, psychiatric, autoimmune, and metabolic comorbidities before and after diagnosis, highlighting their clinical significance as predisposing and prognostic factors in BP patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/26335565261455676","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:57:26Z","timestamp":1779541046000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between bullous pemphigoid and comorbidities: A Swedish nationwide cohort study of 5,738 patients"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9109-1523","authenticated-orcid":false,"given":"Zeyad","family":"Albadri","sequence":"first","affiliation":[{"name":"Division of Cell Biology, Department of Biomedical and Clinical Sciences, The Faculty of Medicine and Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"H\u00e4bel","sequence":"additional","affiliation":[{"name":"Karolinska Institutet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer","family":"Thorslund","sequence":"additional","affiliation":[{"name":"Region S\u00f6rmland County"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Gr\u00f6nhagen","sequence":"additional","affiliation":[{"name":"Lund University"},{"name":"Sk\u00e5ne University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-7142","authenticated-orcid":false,"given":"Oliver","family":"Seifert","sequence":"additional","affiliation":[{"name":"Division of Cell Biology, Department of Biomedical and Clinical Sciences, The Faculty of Medicine and Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Region J\u00f6nk\u00f6ping County"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01506"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1159\/000024364"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yadr.2007.07.013"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.02.030"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13189"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19022"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1778-4"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22504.x"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.4.465"},{"issue":"9","key":"e_1_3_7_11_2","first-page":"1137","article-title":"Bullous pemphigoid: The latest in diagnosis, prognosis, and therapy","volume":"134","author":"Korman NJ","year":"1998","unstructured":"Korman NJ. Bullous pemphigoid: The latest in diagnosis, prognosis, and therapy. Archives of Dermatology 1998; 134(9): 1137\u20131141. https:\/\/doi.org\/10.1001\/archderm.134.9.1137","journal-title":"Archives of Dermatology"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02100-2"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14821"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.05.006"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3622"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2456"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a180"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16970"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)70266-0"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01238"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2352"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295135"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000315393"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13660"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1196999"},{"key":"e_1_3_7_27_2","first-page":"659","article-title":"Bullous pemphigoid and neurodegenerative diseases: A study in a setting of a Central European university dermatology department","volume":"9","author":"Pietkiewicz P","year":"2016","unstructured":"Pietkiewicz P, Gornowicz-Porowska J, Bowszyc-Dmochowska M, et al. Bullous pemphigoid and neurodegenerative diseases: A study in a setting of a Central European university dermatology department. Clinical, Cosmetic and Investigational Dermatology 2016; 9: 659\u2013663. https:\/\/doi.org\/10.1007\/s40520-015-0459-4","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15405"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.357"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.136.4.521"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.5578"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02810-x"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14852"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.596361"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.01.012"},{"key":"e_1_3_7_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.1461"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14902"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1243566"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000505829"},{"issue":"10","key":"e_1_3_7_40_2","first-page":"2098","article-title":"Bullous pemphigoid in a patient with systemic sclerosis (scleroderma)","volume":"33","author":"Sherber NS","year":"2006","unstructured":"Sherber NS, Wigley FM, Anhalt GJ. Bullous pemphigoid in a patient with systemic sclerosis (scleroderma). J Rheumatol 2006; 33(10): 2098.","journal-title":"J Rheumatol"},{"key":"e_1_3_7_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(91)90015-R"},{"issue":"2","key":"e_1_3_7_42_2","first-page":"189","article-title":"Livedoid vasculopathy in a patient with bullous pemphigoid and primary Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Garc\u00eda Briz MI","year":"2020","unstructured":"Garc\u00eda Briz MI, Prats M\u00e1\u00f1ez A, Garc\u00eda Ruiz R, et al. Livedoid vasculopathy in a patient with bullous pemphigoid and primary Sj\u00f6gren\u2019s syndrome. Reumatol Clin (Engl Ed) 2020; 16(2 Pt 2): 189\u2013190. https:\/\/doi.org\/10.1016\/j.reuma.2018.01.013","journal-title":"Reumatol Clin (Engl Ed)"}],"container-title":["Journal of Multimorbidity and Comorbidity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26335565261455676","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/26335565261455676","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26335565261455676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:16:11Z","timestamp":1779714971000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/26335565261455676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"alternative-id":["10.1177\/26335565261455676"],"URL":"https:\/\/doi.org\/10.1177\/26335565261455676","relation":{},"ISSN":["2633-5565","2633-5565"],"issn-type":[{"value":"2633-5565","type":"print"},{"value":"2633-5565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"26335565261455676"}}